JYNT (The Joint) Moat Score: 5/10 (As of Jun. 27, 2026)


JYNT The Joint Corp JYNT
64 GF Score
Price $8.52
GF Value $11.11
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is The Joint Moat Score?

The Joint JYNT -7.49% 64 Moat Score is 5 as of Jun. 27, 2026. GuruFocus rates JYNT with a GF Score™ of 64/100 and a GF Value™ of $11.11 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 681 Healthcare Providers & Services companies, The Joint ranks better than 96.04% on this metric.

The Joint has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

The Joint has Narrow Moat: The Joint Corp benefits from a recognizable brand and customer loyalty in the chiropractic care sector. It has some pricing power and economies of scale, but lacks significant regulatory barriers or proprietary technology.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes The Joint might have Narrow Moat - Solid narrow moat.

The Joint  (NAS:JYNT) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

The Joint Moat Score Related Terms

JYNT vs MAHN, WW, PARK: Moat Score Comparison

For the Medical Care Facilities subindustry, The Joint's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Joint Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, The Joint's Moat Score distribution charts can be found below:

* The bar in red indicates where The Joint's Moat Score falls into.


JYNT
64GF Score
The Joint Corp JYNT
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
The Joint (JYNT) has a Moat Score of 5 as of Jun. 27, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, The Joint ranks #27 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 4%.
Is The Joint's Moat Score too high?
The Joint's current Moat Score is 5. Based on the distribution chart, The Joint ranks #27 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, The Joint has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Joint's Moat Score compare to MAHN and WW?
According to the Healthcare Providers & Services industry distribution chart, The Joint ranks #27 out of 681 companies for Moat Score. This places The Joint in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. The Joint's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Joint stock overvalued right now?
Based on GuruFocus' analysis, The Joint (JYNT) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.11, compared to a current price of $8.52 — trading 23.3% below its estimated fair value. The current Moat Score is 5. The Joint's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For The Joint (JYNT), the current Moat Score is 5 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Joint (JYNT) Overvalued in 2026?

Based on GuruFocus' analysis, The Joint stock appears to be undervalued. The current stock price of $8.52 is trading 23.3% below its estimated GF Value™ of $11.11. GuruFocus considers The Joint to be Modestly Undervalued.

Key valuation signals for JYNT:

  • Moat Score: 5
  • GF Value™: $11.11 vs. price of $8.52 (23.3% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the JYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Joint Business Description

Address 16767 North Perimeter Drive, Suite 110, Scottsdale, AZ, USA, 85260
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
64GF Score

Get the complete analysis for JYNT

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.52
Price
$11.11
GF Value